Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions-Reference-Cited by-同舟云学术

Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions

Published:2020-09 Issue: Volume:181 Page:104873
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Kim So Young^ORCID,Jin Weihua^ORCID,Sood Amika^ORCID,Montgomery David W.^ORCID,Grant Oliver C.,Fuster Mark M.,Fu Li^ORCID,Dordick Jonathan S.^ORCID,Woods Robert J.^ORCID,Zhang Fuming,Linhardt Robert J.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference51 articles.

1. Heparanase, heparan sulfate and viral infection;Agelidis;Adv. Exp. Med. Biol.,2020

2. The association between treatment with heparin and survival in patients with Covid-19;Ayerbe;J. Thromb. Thrombolysis,2020

3. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites;Belouzard;Proc. Natl. Acad. Sci. U. S. A,2009

4. Mechanisms of coronavirus cell entry mediated by the viral spike protein;Belouzard;Viruses,2012

5. Molecular modeling of protein-glycosaminoglycan interactions;Cardin;Arterioscler. Thromb. Vasc. Biol.,1989

Cited by 251 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing traditional Chinese medicine polysaccharides for combatting COVID-19;Carbohydrate Polymers;2024-12

2. Assessment of Supplementation with Different Biomolecules in the Prevention and Treatment of COVID-19;Nutrients;2024-09-11

3. Enzyme-mediated green synthesis of glycosaminoglycans and catalytic process intensification;Biotechnology Advances;2024-09

4. A systematic review of rapid SARS-CoV-2 detection methods for mitigating future outbreaks of emerging or historical pathogens;Microchemical Journal;2024-09

5. Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial;Scientific Reports;2024-08-27